LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

LLY

1,004

-0.33%↓

JNJ

226.76

-1.74%↓

ABBV

210.42

-0.19%↓

UNH

393.66

-1.34%↓

AZN

181.62

-1.79%↓

Home・Elenco Azioni・Alcon Inc

Alcon Inc

Chiusa

SettoreSettore sanitario

63.61 -0.59

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

63.45

Massimo

64.93

Metriche Chiave
By Trading Economics
Entrata	-32M 185M
Vendite	-65M 2.7B
P/E Media del settore	37.138 51.415
EPS	0.85
Rendimento da dividendi	0.58
Margine di Profitto	6.984
Dipendenti	25,000
EBITDA	168M 689M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+43.16% upside

Dividendi
By Dow Jones
Rendimento da dividendi Media del settore	0.58% 2.34%
Utili prossimi	10 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	-6.5B 30B
Apertura precedente	64.2
Chiusura precedente	63.61

Notizie sul Sentiment di mercato

By Acuity

50%

155 / 345 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

95.77 / 97.61 Supporto e resistenza

Alcon Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

17 mar 2026, 14:42 UTC

I principali Market Mover

Acquisizioni, Fusioni, Takeovers

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mar 2026, 21:37 UTC

Acquisizioni, Fusioni, Takeovers

Lensar and Alcon Agree to Terminate Merger

6 gen 2026, 15:11 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 dic 2025, 18:51 UTC

Acquisizioni, Fusioni, Takeovers

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dic 2025, 15:54 UTC

I principali Market Mover

Acquisizioni, Fusioni, Takeovers

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dic 2025, 14:32 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Upgrades Offer Price for Staar Surgical

5 mag 2026, 21:25 UTC

Utili

Alcon Inc. 1Q EPS 39c >ALC.EB

5 mag 2026, 21:25 UTC

Utili

Alcon Inc. 1Q Rev $2.71B >ALC.EB

16 mar 2026, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mar 2026, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mar 2026, 20:59 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mar 2026, 20:57 UTC

Acquisizioni, Fusioni, Takeovers

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 feb 2026, 22:29 UTC

Acquisizioni, Fusioni, Takeovers

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 feb 2026, 22:29 UTC

Acquisizioni, Fusioni, Takeovers

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 feb 2026, 22:28 UTC

Acquisizioni, Fusioni, Takeovers

LENSAR Provides Update on Pending Acquisition by Alcon

24 feb 2026, 21:41 UTC

Utili

Alcon 4Q Rev $2.72B >ALC.EB

7 gen 2026, 01:00 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 gen 2026, 22:03 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 gen 2026, 22:03 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 gen 2026, 15:21 UTC

Discorsi di Mercato

Acquisizioni, Fusioni, Takeovers

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 gen 2026, 14:56 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 gen 2026, 14:14 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 gen 2026, 14:13 UTC

Acquisizioni, Fusioni, Takeovers

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 dic 2025, 14:17 UTC

Acquisizioni, Fusioni, Takeovers

Alcon Ups Offer Price for Staar Surgical

9 dic 2025, 13:34 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dic 2025, 13:33 UTC

Acquisizioni, Fusioni, Takeovers

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

Confronto tra pari

Modifica del prezzo

Alcon Inc Previsione

Obiettivo di Prezzo

By TipRanks

43.16% in crescita

Previsioni per 12 mesi

Media 91.62 USD 43.16%

Alto 109.476 USD

Basso 63.649 USD

Basato su 16 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Alcon Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

16 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 16 che hanno fornito valutazioni azionarie a Alcon Inc - Dist negli ultimi 3 mesi.

Punteggio Tecnico

By Trading Central

95.77 / 97.61Supporto e resistenza

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

155 / 345 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.